|Day Low/High||72.51 / 77.69|
|52 Wk Low/High||75.06 / 308.00|
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
Cannabis is about the only space where I'm long, and that isn't for technical reasons.
There's an expectation that ETF investors increase bullishness and inflows around peaks.
I think I'm likely to remain 'skinny' for now, and prioritize trading over investment at least for the next 10 business days or so.
Money-losing companies, even those who have potentially good prospects, are becoming less valuable on an absolute basis by the amount of their losses.
Homebuilder Toll Brothers is sporting an appealing chart, while Teledoc Health and Peloton Interactive remain names to steer clear of at present.
Recent poor performance has many doubters piping up on the star stock-picker.
The ARK funds are seeing some investor mutiny, but many say they still believe in Wood, her stock picks and her investing philosophy.
Is an incredibly big earnings night the opportunity for a needed washout?
Why we ever allowed Chinese businesses to raise capital, our capital, on our shores, is beyond me.
I'm not looking to play either as the delta variant makes for an uneasy market, but here's what I am looking at right now.
Indications are that it already is, with SolarEdge Technologies appearing to be the best bet of the solar bunch.
Here's a lesson I learned decades ago at Goldman Sachs about how stocks can move in times like this.
Like other momentum stocks, the provider of software to manage digital ad campaigns traded way over its skis and suddenly finds itself tumbling.
* Here's why ARK Invest's holdings are impacting the Nasdaq * ARKK weakness - and the attendant sales of its largest positions - may augur poorly for the Nasdaq in the weeks ahead "Just a small town girl Livin' in a lonely world She took the midnig...
Among other things, results revealed that quite a few firms are now facing a higher bar, and that reopenings have begun affecting consumer behavior in a number of ways.
Roll up your sleeve and know this might hurt a bit: The charts of TDOC show prices are pointed ... lower.
Watch and some of its constituent positions - , , , , etc. Not good. My short thesis on the name seems ever more compelling - with the nail on the ARK Invest perhaps an exodus of investors as outflows begin to rise/mount.
The US Ten Year Note has been on the move, and the US Dollar Index has also been climbing overnight.
ARKK has produced impressive gains but it looks like it is still in a correction phase. Here's what aggressive traders could do.
The name appears bearish and risky right now.
The answer is yes for one of the two stocks that sold off sharply due to forced liquidations by a big shareholder.
You need to respect that a market can be as vicious and nasty as it was joyous and oblivious toward the news that comes its way.
Volume has picked up dramatically since a selloff in the online health services provider began, and it could get worse.
As a very wise man once said: 'I'll gladly pay you Tuesday for a hamburger today.'
Since we don't have a breakout, I would stay with a half-size approach on any trade here.